A detailed history of National Bank Of Canada transactions in Glaukos Corp stock. As of the latest transaction made, National Bank Of Canada holds 560 shares of GKOS stock, worth $68,084. This represents 0.0% of its overall portfolio holdings.

Number of Shares
560
Previous 600 6.67%
Holding current value
$68,084
Previous $56,000 17.86%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$89.48 - $118.35 $3,579 - $4,734
-40 Reduced 6.67%
560 $66,000
Q4 2023

Feb 06, 2024

BUY
$59.53 - $85.11 $35,718 - $51,066
600 New
600 $47,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $5.79B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.